Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 2/2016

01-02-2016 | Pancreatic Tumors

Systematic Review and Meta-Analysis of Enucleation Versus Standardized Resection for Small Pancreatic Lesions

Authors: Terence C. Chua, MBBS, MRCS (Ed), PhD, Timothy X. Yang, MBBS, Anthony J. Gill, MD, FRCPA, Jaswinder S. Samra, DPhil (Oxon), FRACS

Published in: Annals of Surgical Oncology | Issue 2/2016

Login to get access

Abstract

Background

The appropriate surgical strategy in patients with small pancreatic lesions of low malignant potential, such as pancreatic neuroendocrine tumors, remains unknown. Increasing reports suggest limited pancreatic surgery may be a safe option for parenchymal preservation.

Methods

PubMed and MEDLINE were searched in the English literature for studies from January 2000 to February 2015 examining enucleation for pancreatic lesions that were single-arm and comparative studies (versus resection). Single-arm enucleation studies were systematically reviewed. Comparative studies were included for meta-analysis. Endpoints include safety, complications, mortality, survival, and parenchymal-related outcomes.

Results

Thirteen studies comprising of 1101 patients undergoing enucleation were included. Seven studies were comparative studies of enucleation and standardized pancreatic resection. Enucleation was a shorter procedure (pooled mean differences (MD) = 109, 95 % confidence interval (CI) 105–114; Z = 46.37; P < 0.001) associated with less blood loss (pooled MD = 314, 95 % CI 297–330; Z = 37.47; P < 0.001). Both enucleation and resection had similar mortality and complication rates, but the rate of pancreatic fistula (all grades) (pooled odds ratio (OR) = 1.99; 95 % CI 1.2–3.4; Z = 2.57; P = 0.01] and rate of pancreatic fistula (grade B/C) (pooled OR = 1.58; 95 % CI 1.0–2.5; Z = 2.06; P = 0.04) was higher in the enucleation group. Enucleation resulted in lower rates of endocrine (pooled OR = 0.22; 95 % CI 0.1–0.5; Z = 3.21; P = 0.001) and exocrine (pooled OR = 0.07; 95 % CI 0.02–0.2; Z = 5.08; P < 0.001) insufficiency. The median 5-year survival was 95 % (range 93–98) and 84 % (range 79–90).

Conclusions

Enucleation appears to be a safe procedure and achieves parenchymal preservation for small pancreatic lesions of low malignant potential. Its oncologic efficacy compared with standardized pancreatic resection with respect to long-term survival and recurrences have not been reported adequately and hence may not be concluded as being comparable.
Appendix
Available only for authorised users
Literature
1.
Lieberman MD, Kilburn H, Lindsey M, Brennan MF. Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg. 1995;222(5):638–45.PubMedPubMedCentralCrossRef
2.
Samra JS, Bachmann RA, Choi J, Gill A, Neale M, Puttaswamy V, et al. One hundred and seventy-eight consecutive pancreatoduodenectomies without mortality: role of the multidisciplinary approach. Hepatobiliary Pancreat Dis Int. 2011;10(4):415–21.PubMedCrossRef
3.
Tran TC, van Lanschot JJ, Bruno MJ, van Eijck CH. Functional changes after pancreatoduodenectomy: diagnosis and treatment. Pancreatology. 2009;9(6):729–37.PubMedCrossRef
4.
Zeng XJ, Zhong SX, Zhu Y, Fei LM, Wu WJ, Cai LX. Insulinoma: 31 years of tumor localization and excision. J Surg Oncol. 1988;39(4):274–8.PubMedCrossRef
5.
Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063–72.PubMedCrossRef
6.
Chang DK, Johns AL, Merrett ND, Gill AJ, Colvin EK, Scarlett CJ, et al. Margin clearance and outcome in resected pancreatic cancer. J Clin Oncol. 2009;27(17):2855–62.PubMedCrossRef
7.
Birnbaum DJ, Turrini O, Vigano L, Russolillo N, Autret A, Moutardier V, et al. Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study. Ann Surg Oncol. 2014;22(3):1000–7.PubMedCrossRef
8.
Turner RM, Bird SM, Higgins JPT. The impact of study size on meta-analysis: Examination of underpowered studies in cochrane reviews. Plos One. 2013;8(3):e59202.PubMedPubMedCentralCrossRef
9.
Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138(1):8–13.PubMedCrossRef
10.
Gurusamy KS, Koti R, Fusai G, Davidson BR. Somatostatin analogues for pancreatic surgery. Cochrane Database Syst Rev. 2013;4:CD008370.PubMed
11.
12.
13.
Casadei R, Ricci C, Rega D, D’Ambra M, Pezzilli R, Tomassetti P, et al. Pancreatic endocrine tumors less than 4 cm in diameter: resect or enucleate? A single-center experience. Pancreas. 2010;39(6):825–8.PubMedCrossRef
14.
Cauley CE, Pitt HA, Ziegler KM, Nakeeb A, Schmidt CM, Zyromski NJ, et al. Pancreatic enucleation: improved outcomes compared to resection. J Gastrointest Surg. 2012;16:1347–53.PubMedCrossRef
15.
Cherif R, Gaujoux S, Couvelard A, Dokmak S, Vuillerne MP, Ruszniewski P, et al. Parenchyma-sparing resections for pancreatic neuroendocrine tumors. J Gastrointest Surg. 2012;16:2045–55.PubMedCrossRef
16.
Costi R, Randone B, Mal F, Basato S, Levard H, Gayet B. Laparoscopic minor pancreatic resections (enucleations/atypical resections). A long-term appraisal of a supposed mini-invasive approach. Videosurgery Miniinv. 2013;8(2):117–29.CrossRef
17.
Crippa S, Zerbi A, Boninsegna L, Capitanio V, Partelli S, Balzano G, et al. Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections. Arch Surg. 2012;147(3):261–6.PubMedCrossRef
18.
Dedieu A, Rault A, Collet D, Masson B, Sa Cuna A. Laparoscopic enucleation of pancreatic neoplasm. Surg Endosc. 2011;25:572–76.PubMedCrossRef
19.
Hackert T, Hinz U, Fritz S, Strobel O, Schneider L, Hartwig W, et al. Enucleation in pancreatic surgery: indications, technique and outcome compared to standard pancreatic resections. Langenbecks Arch Surg. 2011;396:1197–203.PubMedCrossRef
20.
Hwang HK, Park JS, Kim JK, Park CM, Cho SI, Yoon DS. Comparison of efficacy of enucleation and pancreaticoduodenectomy for small (<3 cm) branch duct type intraductal papillary mucinous neoplasm located at the head of pancreas and the uncinate process. Yonsei Med J. 2012;53(1):106–10.PubMedPubMedCentralCrossRef
21.
Liu H, Peng C, Zhang S, Wu Y, Fang H, Sheng H, et al. Strategy for the surgical management of insulinomas: analysis of 52 cases. Dig Surg. 2007;24:463–70.PubMedCrossRef
22.
Pitt SC, Pitt HA, Baker MS, Christians K, Touzios JG, Kiely JM, et al. Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate? J Gastrointest Surg. 2009;13:1692–8.PubMedPubMedCentralCrossRef
23.
Song KB, Kim SC, Hwang DW, Lee JH, Lee DJ, Lee JW, et al. Enucleation for benign or low-grade malignant lesions of the pancreas: single-center experience with 65 consecutive patients. Surgery. 2014. doi:10.​1016/​j.​surg.​2014.​10.​008.
24.
Zhang T, Xu J, Wang T, Liao Q, Dai M, Zhao Y. Enucleation of pancreatic lesions: indications, outcomes, and risk factors for clinical pancreatic fistula. J Gastrointest Surg. 2013;17(12):2099–104.PubMedCrossRef
25.
Brient C, Regenet N, Sulpice L, Brunaud L, Mucci-Hennekine S, Carrère N, et al. Risk factors for postoperative pancreatic fistulization subsequent to enucleation. J Gastrointest Surg. 2012;16(10):1883–7.PubMedCrossRef
26.
Beger HG, Siech M, Poch B, Mayer B, Schoenberg MH. Limited surgery for benign tumours of the pancreas: a systematic review. World J Surg. 2015;39(6):1557–66.PubMedCrossRef
27.
Park BJ, Alexander HR, Libutti SK, Huang J, Royalty D, Skarulis MC, et al. Operative management of islet-cell tumors arising in the head of the pancreas. Surgery. 1998;124(6):1056–61.PubMedCrossRef
28.
Michiels S, Piedbois P, Burdett S, Syz N, Stewart L, Pignon JP. Meta-analysis when only the median survival times are known: a comparison with individual patient data results. Int J Technol Assess Health Care. 2005;21(1):119–25.PubMedCrossRef
29.
Huang JJ, Yeo CJ, Sohn TA, Lillemoe KD, Sauter PK, Coleman J, et al. Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg. 2000;231(6):890–8.PubMedPubMedCentralCrossRef
30.
Parekh JR, Wang SC, Bergsland EK, Venook AP, Warren RS, Kim GE, et al. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients. Pancreas. 2012;41(6):840–4.PubMedCrossRef
31.
Hashim YM, Trinkaus KM, Linehan DC, Strasberg SS, Fields RC, Cao D, et al. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg. 2014;259(2):197–203.PubMedPubMedCentralCrossRef
Metadata
Title
Systematic Review and Meta-Analysis of Enucleation Versus Standardized Resection for Small Pancreatic Lesions
Authors
Terence C. Chua, MBBS, MRCS (Ed), PhD
Timothy X. Yang, MBBS
Anthony J. Gill, MD, FRCPA
Jaswinder S. Samra, DPhil (Oxon), FRACS
Publication date
01-02-2016
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 2/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4826-3

Other articles of this Issue 2/2016

Annals of Surgical Oncology 2/2016 Go to the issue

Colorectal Cancer

Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer

Breast Oncology

Excising Additional Margins at Initial Breast-Conserving Surgery (BCS) Reduces the Need for Re-excision in a Predominantly African American Population: A Report of a Randomized Prospective Study in a Public Hospital

Endocrine Tumors

Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer

Thoracic Oncology

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis

Gastrointestinal Oncology

Sarcopenia Adversely Impacts Postoperative Clinical Outcomes Following Gastrectomy in Patients with Gastric Cancer: A Prospective Study

Gynecologic Oncology

Which Surgical Attitude to Choose in the Context of Non-Resectability of Ovarian Carcinomatosis: Beyond Gross Residual Disease Considerations